Adverse events of acute nephrotoxicity reported to EudraVigilance and VAERS after COVID-19 vaccination. Anastassopoulou C, Boufidou F, Hatziantoniou S, Vasileiou K, et al. Vaccine 2023 Oct 25:S0264-410X(23)01214-8. doi: 10.1016/j.vaccine.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Anastassopoulou C, Boufidou F, Hatziantoniou S, Vasileiou K, et al. Adverse events of acute nephrotoxicity reported to EudraVigilance and VAERS after COVID-19 vaccination. Vaccine 2023 Oct 25:S0264-410X(23)01214-8. doi: 10.1016/j.vaccine.2023.
PMID: 37891048